Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Yochi Slonim
|
| gptkbp:collaboratedWith |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
drug discovery
mRNA biology |
| gptkbp:foundedYear |
2014
|
| gptkbp:founder |
Limor Shiposh
Yochi Slonim |
| gptkbp:headquartersLocation |
gptkb:Bernardsville,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Anima Biotech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableAchievement |
partnership with Eli Lilly in 2018
|
| gptkbp:specializesIn |
small molecule drugs targeting mRNA translation
|
| gptkbp:technology |
mRNA Lightning platform
|
| gptkbp:website |
https://www.animabiotech.com/
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|